Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NewStem Logo
NewStem Growth Score
22
CB Rank
139030
Heat Score
13
NewStem is a biotechnology startup company a spin-off of Yissum.
Founded
obfuscation
PrivateSeed Jerusalem, Yerushalayim, Israel11-50 newstem.com/
Biopharma
Biotechnology
Life Science
Overview

NewStem
Total Funding
obfuscation
Growth Score
22
Heat Score
13

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score22
-34 pts
in past quarter
Heat Score 13
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NewStem

CB Rank
139030
NewStem is a biotechnology startup company a spin-off of Yissum.
Founded
obfuscation
PrivateSeed Jerusalem, Yerushalayim, Israel11-50 newstem.com/
Biopharma
Biotechnology
Life Science

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name NewStem Ltd.
Operating Status Active
Company Type For Profit
Founders  Nissim Benvenisty
About the Company

NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University. NewStem's technology can predict patients' resistance to chemotherapy allowing for better, targeted cancer

treatments and the potential to reduce resistance to chemotherapy.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Haploid Human Embryonic Stem Cells (HhESCs)
Proprietary stem cells that can differentiate into various cell types while retaining a single set of chromosomes, used for biomedical applications in cancer research, developmental biology, reproductive medicine, and regenerative medicine.
Drug and Gene Screening
Screening capabilities using HhESCs to identify genes and drugs relevant for genetic and epigenetic disorders.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - NewStem Logo
Seed Round - NewStem
1
obfuscation
Illumina AcceleratorSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News

News and Press

News•Apr 12, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$8.8MThis year, NewStem is projected to spend $8.8M on IT, according to Aberdeen.

Active Website Tech Count

3NewStem is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Google Maps, and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is NewStem's headquarters? NewStem is located in Jerusalem, Yerushalayim, Israel.Who invested in NewStem? NewStem has 2 investors including Illumina Accelerator and  Hollywood Media Corp..When was the last funding round for NewStem? NewStem closed its last funding round on
obfuscation
from a Seed round.Who are NewStem's competitors? Alternatives and possible competitors to NewStem may include Synthego, Arima Genomics, and  Albert Einstein College of Medicine.How much funding has NewStem raised to date? NewStem has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|